@article{oai:takasaki-u.repo.nii.ac.jp:00000087,
 author = {Tarn, Christopher},
 issue = {16},
 journal = {高崎健康福祉大学紀要, Bulletin of Takasaki University of Health and Welfare},
 month = {Mar},
 note = {In this paper I want to challenge the effectiveness of the present drugs used for the treatment of depression by challenging the concept that depression is only centered in the brain: treating neurotransmitters such as serotonin, norepinephrine, and dopamine. By neglecting other factors that might have even more weight in the cause of depression such as Inflammation and the influence of the human gut we are taking away valuable tools away from psychiatrists. Not only should we challenge the way present treatment of depression should be performed using more cognitive and behavioral therapies such as CBT, which operates on the basic principle that a person's moods and sense of self are intimately linked with their thoughts, and that recognizing dysfunctional thought patterns and replacing them with healthier ones can lead to improvements in mood, but by also giving psychiatrists a different group of medication that might be a more effective tool to help their suffering patients., 研究論文},
 pages = {117--123},
 title = {Is Depression Linked to Inflammation and the Gut?  An invitation to challenge the methodology of depression therapy through medication in Japan and refocusing the strategy for treatment by including inflammation treatment and incorporating gut flora management},
 year = {2017}
}